Rhone-Poulenc battered
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.PROFITS at Rhone-Poulenc, the newly privatised French chemical and healthcare group, took a worse battering than expected from the European recession last year, writes Gail Counsell.
Net profits fell more than a third to Fr962m ( pounds 113m), partly as a result of restructuring provisions of Fr1.17bn - up from Fr155m in 1992.
The 36 per cent fall was higher than the 30 per cent drop forecast last November by Jean-Rene Fourtou, chairman. However, the figure was within the range anticipated by analysts of Fr800m to Fr1.1bn.
Mr Fourtou said he did not expect any significant improvement in profits before 1996.
The indications were that the recession had bottomed out in the final months of last year, he said, but 1994 would be a year of transition. Rhone was not counting on a genuine upturn in European economies, he added.
The company, which cut its workforce by 6 to 7 per cent last year to about 80,600 people worldwide, is now planning further job cuts and restructuring provisions.
Sales dropped from Fr81.8bn to Fr80.6bn and the gross dividend will fall to Fr3.60 (Fr4.50).
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments